Developmental Biology

Edited by Neeraja Sankaran Seeding Plaques:Peter Lansbury and colleagues identified a possible mechanism for the formation of amyloid plaques in Alzheimer's disease. J.T. Jarrett, E.P. Berger, P.T. Lansbury, Jr., "The carboxy terminus of the b amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease," Biochemistry, 32:4693-7, 1993. (Cited in 53 publications through April 1995) Comments by Peter Lansbury, Jr., Massachusetts Instit

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Edited by Neeraja Sankaran


Seeding Plaques:Peter Lansbury and colleagues identified a possible mechanism for the formation of amyloid plaques in Alzheimer's disease.

J.T. Jarrett, E.P. Berger, P.T. Lansbury, Jr., "The carboxy terminus of the b amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease," Biochemistry, 32:4693-7, 1993. (Cited in 53 publications through April 1995)

Comments by Peter Lansbury, Jr., Massachusetts Institute of Technology

The popularity of this paper in the scientific community, suggests Peter Lansbury, Jr., a professor of chemistry at the Massachusetts Institute of Technology, may be due to the fact that "it was among the first to provide a chemical, mechanistic approach" to explaining the pathogenesis of Alzheimer's disease with respect to amyloid plaque formation.

Although the aggregation of b-amyloid proteins in plaques in the brain has long been recognized as a hallmark of the disease, Lansbury says that until ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies